Elisa Kits

Protocol for the development of a repository of individual participant data from randomised controlled trials conducted in adult care homes (the Virtual International Care Homes Trials Archive (VICHTA))

by
Protocol for the development of a repository of individual participant data from randomised controlled trials conducted in adult care homes (the Virtual International Care Homes Trials Archive (VICHTA))
Approximately 418,000 folks dwell in care homes in the UK, but accessible, sturdy data on care dwelling populations and organisation are missing. This hampers our means to plan, allocate assets or stop threat. Large randomised controlled trials (RCTs) conducted in care homes provide a potential resolution. The worth of detailed data on residents’ demographics, outcomes and contextual info captured in RCTs has but to be absolutely realised. Irrespective of the intervention examined, a lot of the trial data collected overlaps in phrases of structured assessments and descriptive info.
Given the time and prices required to prospectively accumulate data in these populations, pooling anonymised RCT data into a structured repository presents profit; secondary analyses of pooled RCT data can enhance understanding of this under-researched inhabitants and improve the future trial design. This protocol describes the creation of a project-specific repository of individual participant data (IPD) from trials conducted in care homes and subsequent enlargement into a legacy dataset for wider use, to deal with the want for correct, high-quality IPD on this susceptible inhabitants.
Informed by scoping of related literature, the principal investigators of RCTs conducted in adult care homes in the UK since 2010 will probably be invited to contribute trial IPD. Contributing trialists will type a Steering Committee who will oversee data sharing and stay gatekeepers of their very own trial’s data. IPD will probably be cleaned and standardised in session with the Steering Committee for accuracy. Planned analyses embrace a comparability of pooled IPD with level estimates from administrative sources, to evaluate generalisability of RCT data to the wider care dwelling inhabitants.
We may even establish key resident traits and outcomes from inside the trial repository, which is able to inform the development of a nationwide minimal dataset for care homes. Following challenge completion, administration will migrate to the Virtual Trials Archives, forming a legacy dataset which will probably be expanded to incorporate worldwide RCTs, and will probably be accessible to the wider analysis neighborhood for analyses. Analysis of pooled IPD has the potential to tell and direct future follow, analysis and coverage at low value, enhancing the worth of current data and lowering analysis waste. We intention to create a everlasting archive for care dwelling trial data and welcome the contribution of rising trial datasets.

OGP: A Repository of Experimentally Characterized O-Glycoproteins to Facilitate Studies on O-Glycosylation

Numerous research on most cancers, biopharmaceuticals, and medical trials have necessitated complete and exact evaluation of protein O-glycosylation. However, the lack of up to date and handy databases deters the storage of and reference to rising O-glycoprotein data. To resolve this difficulty, an O-glycoprotein repository named OGP was established in this work. It was constructed with a assortment of O-glycoprotein data from completely different sources. OGP accommodates 9354 O-glycosylation websites and 11,633 site-specific O-glycans mapping to 2133 O-glycoproteins, and it’s the largest O-glycoprotein repository to date. Based on the recorded O-glycosylation websites, an O-glycosylation web site prediction instrument was developed.

The first model of OGP repository and the web site enable customers to acquire numerous O-glycoprotein-related info, equivalent to protein accession numbers, O-glycosylation websites, glycopeptide sequences, site-specific glycan constructions, experimental strategies, and potential O-glycosylation websites. To tackle the challenges posed by large-scale development, validation, and adoption of synthetic intelligence (AI) in pathology, now we have constituted a consortium of teachers, small enterprises, and pharmaceutical corporations and proposed the BIGPICTURE challenge to the Innovative Medicines Initiative.

Our imaginative and prescient is to change into the catalyst in the digital transformation of pathology by creating the first European, ethically compliant, and quality-controlled entire slide imaging platform, in which each large-scale data and AI algorithms will exist. Our mission is to develop this platform in a sustainable and inclusive means, by connecting the neighborhood of pathologists, researchers, AI builders, sufferers, and trade events primarily based on creating worth and reciprocity in use primarily based on a neighborhood mannequin as the mechanism for making certain sustainability of the platform.

Protocol for the development of a repository of individual participant data from randomised controlled trials conducted in adult care homes (the Virtual International Care Homes Trials Archive (VICHTA))

Missense3D-DB net catalogue: an atom-based evaluation and repository of 4M human protein-coding genetic variants

The interpretation of human genetic variation is one of the biggest challenges of fashionable genetics. New approaches are urgently wanted to prioritize variants, particularly these which might be uncommon or lack a definitive medical interpretation. We examined 10,136,597 human missense genetic variants from GnomAD, ClinVar and UniProt. We had been capable of carry out large-scale atom-based mapping and phenotype interpretation of 3,960,015 of these variants onto 18,874 experimental and 84,818 in home predicted three-dimensional coordinates of the human proteome.

We show that 14% of amino acid substitutions from the GnomAD database that could possibly be structurally analysed are predicted to have an effect on protein construction (n = 568,548, of which 566,439 uncommon or extraordinarily uncommon) and will, subsequently, have a but unknown disease-causing impact. Moreover, an OGP-based web site is already accessible (http://www.oglyp.org/). The web site contains 4 specifically designed and user-friendly modules: statistical evaluation, database search, web site prediction, and data submission.

Mouse IgG3 Isotype Control (PE)
abx200589-50ug 50 ug
EUR 606

Mouse IgG3 Isotype Control (APC)
abx200590-100ug 100 ug
EUR 732

Mouse IgG3 Isotype Control (PerCP)
abx200591-100ug 100 ug
EUR 732

Mouse IgG3 isotype control, purified
20102-104 100 ug
EUR 141

Mouse IgG3 Isotype control; Concentrate
NG908C 1 ml
EUR 357

Mouse IgG3 Isotype Control (CF-Blue)
abx200592-100ug 100 ug
EUR 481

Mouse IgG3 Isotype Control (OC-515)
abx200593-100ug 100 ug
EUR 606

Mouse IgG3-Biotin conjugate (isotype control)
20102-104-B 50 Tests
EUR 164

Mouse IgG3-FITC conjugate (isotype control)
20102-104-F 50 tests
EUR 164

Mouse IgG3-HRP conjugate (isotype control)
20102-104-HP 50 Tests
EUR 164

Mouse IgG3-PE conjugate (isotype control)
20102-104-PE 50 Tests
EUR 202

Mouse IgG3-PE-Cy5 conjugate (isotype control)
20102-104-PC5 50 Tests
EUR 225

Mouse IgG3 Isotype control; Ready-To-Use
NG908 7 ml
EUR 334

Mouse IgG3 Control
ICIGG3A-50 100 µg
EUR 648

Mouse IgG3 Control
ICIGG3CFB-100 100 µg
EUR 388

Mouse IgG3 Control
ICIGG3F-100 100 µg
EUR 323

Mouse IgG3 Control
ICIGG3PE-50 50 µg
EUR 518

Mouse IgG3 Control
ICIGG3PU-100 100 µg
EUR 323

Mouse IgG3 Isotype Control DyLight® 488
L4-459-C100 0.1 mg
EUR 213

Mouse IgG3 Isotype Control DyLight® 650
L6-459-C100 0.1 mg
EUR 213

Mouse IgM Isotype Control
abx020500-02mg 0.2 mg
EUR 439

Mouse IgG1 Isotype Control
abx405007-01mg 0.1 mg
EUR 411

Mouse IgG1 Isotype Control
abx405009-05mg 0.5 mg
EUR 690

Mouse IgG1 Isotype Control
abx405012-1mg 1 mg
EUR 1080

Mouse IgG2a Isotype Control
abx405013-100tests 100 tests
EUR 411

Mouse IgG2a Isotype Control
abx405015-05mg 0.5 mg
EUR 690

Mouse IgG2a Isotype Control
abx405018-1mg 1 mg
EUR 1107

Mouse IgG2b Isotype Control
abx405056-100tests 100 tests
EUR 411

Mouse IgG2b Isotype Control
abx405061-1mg 1 mg
EUR 1080

Mouse IgM Isotype Control
abx405062-100tests 100 tests
EUR 411

Mouse IgG1 Isotype Control
abx405064-100tests 100 tests
EUR 411

Mouse IgG1 Isotype Control
abx405067-05mg 0.5 mg
EUR 829

Mouse IgG2a Isotype Control
abx405070-100tests 100 tests
EUR 411

Mouse IgG2a Isotype Control
abx405073-05mg 0.5 mg
EUR 829

Mouse IgG1 Isotype Control
abx200564-100ug 100 ug
EUR 314

Mouse IgG2a Isotype Control
abx200572-100ug 100 ug
EUR 314

Mouse IgG2b Isotype Control
abx200580-100ug 100 ug
EUR 314

Mouse IgM Isotype Control
abx200594-100ug 100 ug
EUR 314

Mouse IgG1 Isotype Control
abx139001-01mg 0.1 mg
EUR 314

Mouse IgG1 Isotype Control
abx139002-01mg 0.1 mg
EUR 314

Mouse IgM Isotype Control
abx139003-01mg 0.1 mg
EUR 314

Mouse IgG2a Isotype Control
abx139004-01mg 0.1 mg
EUR 314

Mouse IgG1 Isotype Control
abx139008-01mg 0.1 mg
EUR 314

Mouse IgG2a Isotype Control
abx139005-01mg 0.1 mg
EUR 314

Mouse IgG2b Isotype Control
abx139006-01mg 0.1 mg
EUR 314

Mouse IgG2a Isotype Control
abx139009-01mg 0.1 mg
EUR 314

Mouse IgG2b Isotype Control
abx139011-01mg 0.1 mg
EUR 314

Mouse IgG Isotype Control
IC002-100ul 100ul
EUR 122

Mouse IgG2a Isotype Control
10R-I117d 1 mg
EUR 553
Description: Purified Mouse IgG2a Isotype Control

Rat IgG-Biotin conjugate (isotype control) (Isotype control)
20005-B 100 ug
EUR 164

Rat IgG-FITC conjugate (isotype control) (Isotype control)
20005-F 100 ug
EUR 164

Rat IgG-HRP conjugate (isotype control) (Isotype control)
20005-HP 100 ug
EUR 164

Rat IgG-PE conjugate (isotype control) (Isotype control)
20005-PE 25 tests
EUR 202

Rabbit Isotype Control
abx200646-100ug 100 ug
EUR 328

Rabbit Isotype Control
IMN-001 100 µg
EUR 199.5

Mouse IgG1 Isotype Control PerCP
PC-632-C025 0.025 mg
EUR 136

Mouse IgG1 Isotype Control PerCP
PC-632-C100 0.1 mg
EUR 231

Mouse IgG2b Isotype Control PerCP
PC-692-C025 0.025 mg
EUR 122

Mouse IgG2b Isotype Control PerCP
PC-692-C100 0.1 mg
EUR 204

Mouse IgG2a Isotype Control PerCP
PC-724-C025 0.025 mg
EUR 122

Mouse IgG2a Isotype Control PerCP
PC-724-C100 0.1 mg
EUR 204

Mouse IgG1 Isotype Control APC
1A-632-C025 0.025 mg
EUR 122

Mouse IgG1 Isotype Control APC
1A-632-C100 0.1 mg
EUR 204

Mouse IgG2b Isotype Control APC
1A-692-C025 0.025 mg
EUR 122

Mouse IgG2b Isotype Control APC
1A-692-C100 0.1 mg
EUR 204

Mouse IgG2a Isotype Control APC
1A-724-C025 0.025 mg
EUR 122

Mouse IgG2a Isotype Control APC
1A-724-C100 0.1 mg
EUR 204

Mouse IgG1 Isotype Control Biotin
1B-632-C025 0.025 mg
EUR 108

Mouse IgG1 Isotype Control Biotin
1B-632-C100 0.1 mg
EUR 177

Mouse IgG2b Isotype Control Biotin
1B-692-C025 0.025 mg
EUR 108

Mouse IgG2b Isotype Control Biotin
1B-692-C100 0.1 mg
EUR 177

Mouse IgG2a Isotype Control Biotin
1B-724-C025 0.025 mg
EUR 108

Mouse IgG2a Isotype Control Biotin
1B-724-C100 0.1 mg
EUR 177

Mouse IgG1 Isotype Control FITC
1F-632-C025 0.025 mg
EUR 108

Mouse IgG1 Isotype Control FITC
1F-632-C100 0.1 mg
EUR 177

Mouse IgG2b Isotype Control FITC
1F-692-C025 0.025 mg
EUR 108

Mouse IgG2b Isotype Control FITC
1F-692-C100 0.1 mg
EUR 177

Mouse IgG2a Isotype Control FITC
1F-724-C025 0.025 mg
EUR 108

Mouse IgG2a Isotype Control FITC
1F-724-C100 0.1 mg
EUR 177

Mouse IgM Isotype Control FITC
1F-803-C025 0.025 mg
EUR 108

Mouse IgM Isotype Control FITC
1F-803-C100 0.1 mg
EUR 177

Mouse IgG1 Isotype Control PE
1P-632-C025 0.025 mg
EUR 122

Mouse IgG1 Isotype Control PE
1P-632-C100 0.1 mg
EUR 204

Mouse IgG2b Isotype Control PE
1P-692-C025 0.025 mg
EUR 122

Mouse IgG2b Isotype Control PE
1P-692-C100 0.1 mg
EUR 204

Mouse IgG2a Isotype Control PE
1P-724-C025 0.025 mg
EUR 122

Mouse IgG2a Isotype Control PE
1P-724-C100 0.1 mg
EUR 204

Mouse IgM Isotype Control PE
1P-803-C025 0.025 mg
EUR 122

Mouse IgM Isotype Control PE
1P-803-C100 0.1 mg
EUR 204

Mouse IgG1 Isotype Control Purified
11-457-C025 0.025 mg
EUR 88

Mouse IgG1 Isotype Control Purified
11-457-C100 0.1 mg
EUR 136

Mouse IgG2a Isotype Control Purified
11-458-C025 0.025 mg
EUR 88

Mouse IgG2a Isotype Control Purified
11-458-C100 0.1 mg
EUR 136

Mouse IgG1 Isotype Control Purified
11-632-C025 0.025 mg
EUR 87

Mouse IgG1 Isotype Control Purified
11-632-C100 0.1 mg
EUR 136

Mouse IgG2b Isotype Control Purified
11-692-C025 0.025 mg
EUR 88

Mouse IgG2b Isotype Control Purified
11-692-C100 0.1 mg
EUR 136

Mouse IgG2a Isotype Control Purified
11-724-C025 0.025 mg
EUR 88

Mouse IgG2a Isotype Control Purified
11-724-C100 0.1 mg
EUR 136

Mouse IgG2b Isotype Control Purified
11-801-C025 0.025 mg
EUR 88

Mouse IgG2b Isotype Control Purified
11-801-C100 0.1 mg
EUR 136

Mouse IgM Isotype Control Purified
11-803-C025 0.025 mg
EUR 87

Mouse IgM Isotype Control Purified
11-803-C100 0.1 mg
EUR 136

Mouse IgG1 Isotype Control (Biotin)
abx405008-01mg 0.1 mg
EUR 509

Mouse IgG1 Isotype Control (FITC)
abx405010-01mg 0.1 mg
EUR 509

Mouse IgG1 Isotype Control (RPE)
abx405011-100tests 100 tests
EUR 634

Mouse IgG2a Isotype Control (Biotin)
abx405014-01mg 0.1 mg
EUR 411

Mouse IgG2a Isotype Control (FITC)
abx405016-01mg 0.1 mg
EUR 509

Mouse IgG2a Isotype Control (RPE)
abx405017-100tests 100 tests
EUR 634

Mouse IgG2b Isotype Control (APC)
abx405057-100tests 100 tests
EUR 481

Mouse IgG2b Isotype Control (Biotin)
abx405058-100tests 100 tests
EUR 411

Mouse IgG2b Isotype Control (FITC)
abx405059-100tests 100 tests
EUR 411

Mouse IgG2b Isotype Control (RPE)
abx405060-100tests 100 tests
EUR 467

Mouse IgM Isotype Control (FITC)
abx405063-01mg 0.1 mg
EUR 411

Mouse IgG1 Isotype Control (APC)
abx405065-100tests 100 tests
EUR 411

Mouse IgG1 Isotype Control (Biotin)
abx405066-100tests 100 tests
EUR 411

Mouse IgG1 Isotype Control (FITC)
abx405068-100tests 100 tests
EUR 411

Mouse IgG1 Isotype Control (RPE)
abx405069-100tests 100 tests
EUR 467

Mouse IgG2a Isotype Control (APC)
abx405071-100tests 100 tests
EUR 425

Mouse IgG2a Isotype Control (Biotin)
abx405072-100tests 100 tests
EUR 411

Mouse IgG2a Isotype Control (FITC)
abx405074-100tests 100 tests
EUR 411

Mouse IgG2a Isotype Control (RPE)
abx405075-100tests 100 tests
EUR 467

Mouse IgG1 Isotype Control (FITC)
abx200565-100ug 100 ug
EUR 314

Mouse IgG1 Isotype Control (PE)
abx200566-50ug 50 ug
EUR 425

Mouse IgG1 Isotype Control (APC)
abx200567-50ug 50 ug
EUR 425

Mouse IgG1 Isotype Control (PerCP)
abx200568-100ug 100 ug
EUR 425

Mouse IgG2a Isotype Control (FITC)
abx200573-100ug 100 ug
EUR 314

Mouse IgG2a Isotype Control (PE)
abx200574-50ug 50 ug
EUR 425

Mouse IgG2a Isotype Control (APC)
abx200575-50ug 50 ug
EUR 425

Mouse IgG2a Isotype Control (PerCP)
abx200576-100ug 100 ug
EUR 425

Mouse IgG2b Isotype Control (FITC)
abx200581-100ug 100 ug
EUR 314

Mouse IgG2b Isotype Control (PE)
abx200582-50ug 50 ug
EUR 425

the similar is true for 19.0% (n = 6266) of variants of unknown medical significance or conflicting interpretation reported in the ClinVar database. The outcomes of the structural evaluation can be found in the devoted net catalogue Missense3D-DB. For every of the four M variants, the outcomes of the structural evaluation are introduced in a pleasant concise format that may be included in medical genetic stories. An in depth report of the structural evaluation can also be accessible for the non-experts in structural biology. Population frequency and predictions from SIFT and PolyPhen are included for a extra complete variant interpretation. This is the first large-scale atom-based structural interpretation of human genetic variation and presents geneticists and the biomedical neighborhood a new method to genetic variant interpretation.

A content-based dataset recommendation system for researchers-a case study on Gene Expression Omnibus (GEO) repository

by
A content-based dataset recommendation system for researchers-a case study on Gene Expression Omnibus (GEO) repository

It is a rising development amongst researchers to make their knowledge publicly obtainable for experimental reproducibility and knowledge reusability. Sharing knowledge with fellow researchers helps in growing the visibility of the work. On the opposite hand, there are researchers who’re inhibited by the shortage of knowledge sources. To overcome this problem, many repositories and data bases have been established to this point to ease knowledge sharing. Further, prior to now 20 years, there was an exponential enhance within the variety of datasets added to those dataset repositories.

However, most of those repositories are domain-specific, and none of them can advocate datasets to researchers/customers. Naturally, it’s difficult for a researcher to maintain monitor of all of the related repositories for potential use. Thus, a dataset recommender system that recommends datasets to a researcher primarily based on earlier publications can improve their productiveness and expedite additional analysis. The potential to focus onto subnetworks, a number of visualizations and simulation choices will allow the AMD analysis neighborhood to computationally mannequin subnetworks or to check experimentally new hypotheses arising from connectivities in the AMD pathway map.

This work adopts an info retrieval (IR) paradigm for dataset recommendation. We hypothesize that two elementary variations exist between dataset recommendation and PubMed-style biomedical IR past the corpus. First, as an alternative of key phrases, the question is the researcher, embodied by his or her publications. Second, to filter the related datasets from non-relevant ones, researchers are higher represented by a set of pursuits, versus your entire physique of their analysis. This second strategy is applied utilizing a non-parametric clustering method.

These clusters are used to advocate datasets for every researcher utilizing the cosine similarity between the vector representations of publication clusters and datasets. The most normalized discounted cumulative acquire at 10 (NDCG@10), precision at 10 (p@10) partial and p@10 strict of 0.89, 0.78 and 0.61, respectively, have been obtained utilizing the proposed methodology after handbook analysis by 5 researchers. As per one of the best of our data, that is the primary study of its variety on content-based dataset recommendation.

Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks

To facilitate scientific collaboration on polygenic threat scores (PRSs) analysis, we created an intensive PRS on-line repository for 35 frequent most cancers traits integrating freely obtainable genome-wide affiliation research (GWASs) abstract statistics from three sources: printed GWASs, the NHGRI-EBI GWAS Catalog, and UK Biobank-based GWASs. Our framework condenses these abstract statistics into PRSs utilizing varied approaches comparable to linkage disequilibrium pruning/p worth thresholding (mounted or data-adaptively optimized thresholds) and penalized, genome-wide impact dimension weighting.
We evaluated the PRSs in two biobanks: the Michigan Genomics Initiative (MGI), a longitudinal biorepository effort at Michigan Medicine, and the population-based UK Biobank (UKB). For every PRS assemble, we offer measures on predictive efficiency and discrimination. Besides PRS analysis, the Cancer-PRSweb platform options assemble downloads and phenome-wide PRS affiliation study outcomes (PRS-PheWAS) for predictive PRSs. We count on this built-in platform to speed up PRS-related most cancers analysis.
This multicenter, double-blind, randomized, placebo-controlled study enrolled sufferers ≥ 18 years with lively SLE and reasonable to extreme rash and/or arthritis regardless of steady glucocorticoid doses (7.5-30 mg/day prednisone equal) and antimalarials for ≥ Four weeks and/or immunosuppressants for ≥ eight weeks earlier than screening. Stable glucocorticoid doses have been required by way of week 16 with optionally available taper from weeks 16 to 24.
Patients have been randomized (1:1) to 80 U RCI subcutaneously or placebo each different day to week 4, then twice weekly to week 24. Endpoints included the proportion of SLE Responder Index (SRI)-Four responders at week 16; modifications from baseline to week 16 in 28 Swollen Joint Count/Tender Joint Count (28 SJC/TJC) and Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI)-Activity rating; and modifications from baseline to week 24 in inflammatory cytokines. Safety was assessed by antagonistic occasions.
A content-based dataset recommendation system for researchers-a case study on Gene Expression Omnibus (GEO) repository

Advancing COVID-19 differentiation with a sturdy preprocessing and integration of multi-institutional open-repository laptop tomography datasets for deep studying evaluation

The coronavirus pandemic and its unprecedented penalties globally has spurred the curiosity of the synthetic intelligence analysis neighborhood. A plethora of printed research have investigated the position of imaging comparable to chest X-rays and laptop tomography in coronavirus illness 2019 (COVID-19) automated analysis. Οpen repositories of medical imaging knowledge can play a big position by selling cooperation amongst institutes in a world-wide scale. However, they might induce limitations associated to variable knowledge high quality and intrinsic variations because of the huge number of scanner distributors and imaging parameters.

In this study, a state-of-the-art customized U-Net mannequin is offered with a cube similarity coefficient efficiency of 99.6% together with a switch studying VGG-19 primarily based mannequin for COVID-19 versus pneumonia differentiation exhibiting an space underneath curve of 96.1%. The above was considerably improved over the baseline mannequin skilled with no segmentation in chosen tomographic slices of the identical dataset. The offered study highlights the significance of a sturdy preprocessing protocol for picture evaluation inside a heterogeneous imaging dataset and assesses the potential diagnostic worth of the offered COVID-19 mannequin by evaluating its efficiency to the state-of-the-art. Health-related knowledge is saved in various repositories which can be managed and managed by completely different entities.

Chicken IgY
E61I020 100ug
EUR 343

Chicken IgY
31-AC25 50 mg
EUR 270
Description: Purified Chicken IgY

Rat IgG-Biotin conjugate (isotype control) (Isotype control)
20005-B 100 ug
EUR 164

Rat IgG-FITC conjugate (isotype control) (Isotype control)
20005-F 100 ug
EUR 164

Rat IgG-HRP conjugate (isotype control) (Isotype control)
20005-HP 100 ug
EUR 164

Rat IgG-PE conjugate (isotype control) (Isotype control)
20005-PE 25 tests
EUR 202

Rabbit Isotype Control
abx200646-100ug 100 ug
EUR 328

Rabbit Isotype Control
IMN-001 100 µg
EUR 199.5

Chicken IgY Protein
abx060688-50mg 50 mg
EUR 551

Chicken IgY Protein
abx060689-10ml 10 ml
EUR 495

Chicken IgY Protein
abx061434-1g 1 g
EUR 676

Chicken IgY (Unconjugated)
LF-SA8052 5 mg
EUR 181
Description: Normal chicken yolk

Chicken IgY (Unconjugated)
LF-SA8052A 10 mg
EUR 296
Description: Normal chicken yolk

Chicken IgG unlabeled (isotype control, non-immune), purified
20010-1 1 mg
EUR 141

Custom purification of IgY from up to 6 egg yolks
IGY-1 1
EUR 651

Custom purification of IgY from up to 12 egg yolks
IGY-2 1
EUR 895

Positive control tissue section for each antibody; Based on availability INQUIRE
Control-Slides Set of 5
EUR 176

Chicken IgG-Biotin conjugate (isotype control, non-immune), purified
20010-1-B 0.5 mg
EUR 225

Chicken IgG-FITC conjugate (isotype control, non-immune), purified
20010-1-F 0.5 mg
EUR 225

Chicken IgG-HRP conjugate (isotype control, non-immune), purified
20010-1-HP 0.5 mg
EUR 225

Chicken IgM-Biotin conjugate (isotype control, non-immune) purified
20010-2-1-b 0.1 mg
EUR 225

Chicken IgG-Fc unlabeled (isotype control, non-immune), purified
20010-3-UL 0.1 mg
EUR 202

Chicken IgG Fab fragment (isotype control, non-immune), purified
20010-Fab-1 0.5 mg
EUR 225

Rabbit IgG Isotype Control
abx125003-100ul 100 ul
EUR 203

Mouse IgM Isotype Control
abx020500-02mg 0.2 mg
EUR 439

Rat IgG2a Isotype Control
11-168-C025 0.025 mg
EUR 87

Rat IgG2b Isotype Control
11-169-C025 0.025 mg
EUR 87

Mouse IgG1 Isotype Control
abx405007-01mg 0.1 mg
EUR 411

Mouse IgG1 Isotype Control
abx405009-05mg 0.5 mg
EUR 690

Mouse IgG1 Isotype Control
abx405012-1mg 1 mg
EUR 1080

Mouse IgG2a Isotype Control
abx405013-100tests 100 tests
EUR 411

Mouse IgG2a Isotype Control
abx405015-05mg 0.5 mg
EUR 690

Mouse IgG2a Isotype Control
abx405018-1mg 1 mg
EUR 1107

Rat IgG1 Isotype Control
abx405020-05mg 0.5 mg
EUR 384

Rat IgG2a Isotype Control
abx405022-1ml 1 ml
EUR 300

Rat IgG2a Isotype Control
abx405024-05mg 0.5 mg
EUR 384

Rat IgG2a Isotype Control
abx405027-1mg 1 mg
EUR 565

Rat IgG2c Isotype Control
abx405034-025mg 0.25 mg
EUR 537

Mouse IgG3 Isotype Control
abx405035-01mg 0.1 mg
EUR 411

Rat IgG1 Isotype Control
abx405039-05mg 0.5 mg
EUR 384

Rat IgG1 Isotype Control
20-abx405041
  • EUR 300.00
  • EUR 439.00
  • 0.1 mg
  • 1 mg

Rat IgG2a Isotype Control
abx405045-05mg 0.5 mg
EUR 384

Rat IgG2a Isotype Control
20-abx405047
  • EUR 300.00
  • EUR 439.00
  • 0.1 mg
  • 1 mg

Rat IgG2b Isotype Control
abx405051-05mg 0.5 mg
EUR 384

Rat IgG2b Isotype Control
20-abx405053
  • EUR 300.00
  • EUR 439.00
  • 0.1 mg
  • 1 mg

Mouse IgG2b Isotype Control
abx405056-100tests 100 tests
EUR 411

Mouse IgG2b Isotype Control
abx405061-1mg 1 mg
EUR 1080

Mouse IgM Isotype Control
abx405062-100tests 100 tests
EUR 411

Mouse IgG1 Isotype Control
abx405064-100tests 100 tests
EUR 411

Mouse IgG1 Isotype Control
abx405067-05mg 0.5 mg
EUR 829

Mouse IgG2a Isotype Control
abx405070-100tests 100 tests
EUR 411

Mouse IgG2a Isotype Control
abx405073-05mg 0.5 mg
EUR 829

Mouse IgG1 Isotype Control
abx200564-100ug 100 ug
EUR 314

Mouse IgG2a Isotype Control
abx200572-100ug 100 ug
EUR 314

Mouse IgG2b Isotype Control
abx200580-100ug 100 ug
EUR 314

Mouse IgG3 Isotype Control
abx200587-100ug 100 ug
EUR 356

Mouse IgM Isotype Control
abx200594-100ug 100 ug
EUR 314

Rat IgG2a Isotype Control
abx200644-500ug 500 ug
EUR 481

Rabbit Isotype Control (FITC)
abx200647-100test 100 test
EUR 328

Rabbit Isotype Control (PE)
abx200648-100test 100 test
EUR 328

Mouse IgG1 Isotype Control
abx139001-01mg 0.1 mg
EUR 314

Mouse IgG1 Isotype Control
abx139002-01mg 0.1 mg
EUR 314

Mouse IgM Isotype Control
abx139003-01mg 0.1 mg
EUR 314

Mouse IgG2a Isotype Control
abx139004-01mg 0.1 mg
EUR 314

Mouse IgG1 Isotype Control
abx139008-01mg 0.1 mg
EUR 314

Mouse IgG3 Isotype Control
abx139010-01mg 0.1 mg
EUR 314

Mouse IgG2a Isotype Control
abx139005-01mg 0.1 mg
EUR 314

Mouse IgG2b Isotype Control
abx139006-01mg 0.1 mg
EUR 314

Mouse IgG2a Isotype Control
abx139009-01mg 0.1 mg
EUR 314

Mouse IgG2b Isotype Control
abx139011-01mg 0.1 mg
EUR 314

Rat IgG1 Isotype Control
RIGG1A-100 100 µg
EUR 545.04

Rat IgG1 Isotype Control
RIGG1A-25 25 µg
EUR 268.4

Rat IgG1 Isotype Control
RIGG1F-50 50 µg
EUR 297.52

Rat IgG1 Isotype Control
RIGG1F-500 500 µg
EUR 879.92

Rat IgG1 Isotype Control
RIGG1PE-100 100 µg
EUR 530.48

Rat IgG1 Isotype Control
RIGG1PE-25 25 µg
EUR 253.84

Rat IgG1 Isotype Control
RIGG1PP5.5-100 100 µg
EUR 588.72

Rat IgG1 Isotype Control
RIGG1PP5.5-25 25 µg
EUR 268.4

Rat IgG1 Isotype Control
RIGG1PU-50 50 µg
EUR 181.04

Rat IgG1 Isotype Control
RIGG1PU-500 500 µg
EUR 399.44

Rat IgG2a Isotype Control
RIGG2AA-100 100 µg
EUR 312.08

Rat IgG2a Isotype Control
RIGG2AA-25 25 µg
EUR 181.04

Rat IgG2a Isotype Control
RIGG2AB-200 200 µg
EUR 457.68

Rat IgG2a Isotype Control
RIGG2AB-50 50 µg
EUR 224.72

Rat IgG2a Isotype Control
RIGG2AF-200 200 µg
EUR 312.08

Rat IgG2a Isotype Control
RIGG2AF-50 50 µg
EUR 166.48

Rat IgG2a Isotype Control
RIGG2APE-100 100 µg
EUR 282.96

Rat IgG2a Isotype Control
RIGG2APE-25 25 µg
EUR 166.48

Rat IgG2a Isotype Control
RIGG2APP-100 100 µg
EUR 574.16

Rat IgG2a Isotype Control
RIGG2APP-25 25 µg
EUR 268.4

Rat IgG2a Isotype Control
RIGG2APP5.5-100 100 µg
EUR 646.96

Rat IgG2a Isotype Control
RIGG2APP5.5-25 25 µg
EUR 282.96

Rat IgG2a Isotype Control
RIGG2APU-50 50 µg
EUR 181.04

Rat IgG2a Isotype Control
RIGG2APU-500 500 µg
EUR 399.44

Rat IgG2b Isotype Control
RIGG2BA-100 100 µg
EUR 326.64

Rat IgG2b Isotype Control
RIGG2BA-25 25 µg
EUR 166.48

Rat IgG2b Isotype Control
RIGG2BB-200 200 µg
EUR 457.68

Rat IgG2b Isotype Control
RIGG2BB-50 50 µg
EUR 224.72

Rat IgG2b Isotype Control
RIGG2BF-200 200 µg
EUR 472.24

Rat IgG2b Isotype Control
RIGG2BF-50 50 µg
EUR 151.92

Rat IgG2b Isotype Control
RIGG2BPE-100 100 µg
EUR 268.4

Rat IgG2b Isotype Control
RIGG2BPE-25 25 µg
EUR 151.92

Rat IgG2b Isotype Control
RIGG2BPP-100 100 µg
EUR 574.16

Rat IgG2b Isotype Control
RIGG2BPP-25 25 µg
EUR 268.4

Rat IgG2b Isotype Control
RIGG2BPP5.5-100 100 µg
EUR 515.92

Rat IgG2b Isotype Control
RIGG2BPP5.5-25 25 µg
EUR 282.96

Rat IgG2b Isotype Control
RIGG2BPU-50 50 µg
EUR 122.8

Rat IgG2b Isotype Control
RIGG2BPU-500 500 µg
EUR 370.32

Rat IgG2c Isotype Control
RIGG2CA-25 25 µg
EUR 253.84

Rat IgG2c Isotype Control
RIGG2CB-50 50 µg
EUR 224.72

Rat IgG2c Isotype Control
RIGG2CF-50 50 µg
EUR 253.84

Rat IgG2c Isotype Control
RIGG2CPE-25 25 µg
EUR 239.28

Rat IgG2c Isotype Control
RIGG2CPP5.5-25 25 µg
EUR 282.96

Rat IgG2c Isotype Control
RIGG2CPU-50 50 µg
EUR 181.04

Rat IgG2c Isotype Control
RIGG2CPU-500 500 µg
EUR 399.44

Rat IgM Isotype Control
RIGMA-100 100 µg
EUR 705.2

Rat IgM Isotype Control
RIGMB-200 200 µg
EUR 778

Rat IgM Isotype Control
RIGMB-50 50 µg
EUR 253.84

Rat IgM Isotype Control
RIGMF-200 200 µg
EUR 778

Rat IgM Isotype Control
RIGMF-50 50 µg
EUR 253.84

Rat IgM Isotype Control
RIGMPE-100 100 µg
EUR 457.68

Rat IgM Isotype Control
RIGMPE-25 25 µg
EUR 239.28

Rat IgM Isotype Control
RIGMPP5.5-25 25 µg
EUR 355.76

Rat IgM Isotype Control
RIGMPU-50 50 µg
EUR 181.04

Rat IgM Isotype Control
RIGMPU-500 500 µg
EUR 399.44

Rabbit IgG Isotype Control
IC001-100ul 100ul
EUR 122

Mouse IgG Isotype Control
IC002-100ul 100ul
EUR 122

IgG Isotype Control antibody
10R-6524 50 ug
EUR 133
Description: Armenian Hamster monoclonal IgG Isotype Control antibody

IgG Isotype Control antibody
10R-6525 50 ug
EUR 133
Description: Syrian Hamster monoclonal IgG Isotype Control antibody

Mouse IgG2a Isotype Control
10R-I117d 1 mg
EUR 553
Description: Purified Mouse IgG2a Isotype Control

Rat IgG Isotype Control
31-AR15 10 mg
EUR 220
Description: Purified Rat IgG Isotype Control

Rat IgG2b Isotype Control
31R-IC001 500 ug
EUR 241
Description: Purified Rat IgG2b Isotype Control

Rabbit anti Chicken IgY
E61I0201 100ug
EUR 343

Anti-Chicken IgY antibody
STJ16100614 100 µg
EUR 813

Anti-Chicken IgY antibody
STJ16100615 50 µg
EUR 645

Anti-Chicken IgY antibody
STJ16101246 1 mg
EUR 191

Anti-Chicken IgY antibody
STJ16101247 1.2 mg
EUR 229

Anti-Chicken IgY antibody
STJ16101248 1.2 mg
EUR 282

Anti-Chicken IgY antibody
STJ16101363 1 mg
EUR 191

Anti-Chicken IgY antibody
STJ16101364 1.2 mg
EUR 229

Anti-Chicken IgY antibody
STJ16101365 1.2 mg
EUR 282

Chicken IgY ELISA Kit
E-30Y 1 x 96 well plate
EUR 395

Rabbit anti Chicken IgY
20-B9093R000-R0 5 ml
EUR 138
Description: Rabbit anti Chicken IgY antibody

Chicken IgY precipitation reagent
85R-1010 4 ml
EUR 554
Description: Chicken IgY precipitation reagent for use in immunoassays

Chicken IgY (Non Immune)
31R-1052 1 ml
EUR 148
Description: Purified Chicken non immune IgY

Donkey IgG (Control, non-immune, isotype control)
20028-1 1 mg
EUR 164

Chicken IgG-Fc-Biotin conjugate (isotype control, non-immune), purified
20010-3-B 0.1 mg
EUR 225

Chicken IgG-Fc-FITC conjugate (isotype control, non-immune), purified
20010-3-F 0.1 mg
EUR 225

Chicken IgG-Fc-HRP conjugate (isotype control, non-immune), purified
20010-3-HP 0.1 mg
EUR 225

Mouse IgG1 Isotype Control PerCP
PC-632-C025 0.025 mg
EUR 136

Mouse IgG1 Isotype Control PerCP
PC-632-C100 0.1 mg
EUR 231

Mouse IgG2b Isotype Control PerCP
PC-692-C025 0.025 mg
EUR 122

Mouse IgG2b Isotype Control PerCP
PC-692-C100 0.1 mg
EUR 204

Mouse IgG2a Isotype Control PerCP
PC-724-C025 0.025 mg
EUR 122

Mouse IgG2a Isotype Control PerCP
PC-724-C100 0.1 mg
EUR 204

Mouse IgG1 Isotype Control APC
1A-632-C025 0.025 mg
EUR 122

Mouse IgG1 Isotype Control APC
1A-632-C100 0.1 mg
EUR 204

Mouse IgG2b Isotype Control APC
1A-692-C025 0.025 mg
EUR 122

Mouse IgG2b Isotype Control APC
1A-692-C100 0.1 mg
EUR 204

Mouse IgG2a Isotype Control APC
1A-724-C025 0.025 mg
EUR 122

For occasion, Electronic Health Records are normally administered by governments. Electronic Medical Records are sometimes managed by well being care suppliers, whereas Personal Health Records are managed straight by sufferers. Recently, Blockchain-based well being report programs largely regulated by know-how have emerged as one other sort of repository. Repositories for storing well being knowledge differ from each other primarily based on price, stage of safety and high quality of efficiency. Not solely has the kind of repositories elevated lately, however the quantum of well being knowledge to be saved has elevated.